Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder, Overactive

Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.

89 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder, Overactive trial results

Not Yet Recruiting

Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy

NCT07227285

Conditions
Central Nervous System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • Rancho Los Amigos National Rehabilitation Center Downey, California, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Sidney Kimmel Medical College Philadelphia, Pennsylvania, United States
  • UTHealth Houston / TIRR Memorial Hermann Houston, Texas, United States
View Trial Details
Not Yet Recruiting

The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial

NCT07114640

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao District, New Taipei, Taiwan
View Trial Details
Completed

FemPulse Therapy for Overactive Bladder in Women

NCT03784170

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Minnesota Urology Woodbury, Minnesota, United States
  • McKay Urology Charlotte, North Carolina, United States
  • University of Washington Medical Center Seattle, Washington, United States
View Trial Details
Completed

Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder

NCT01558856

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Clinique Beau Soleil Montpellier, France
  • CHU de Nantes - Hôtel Dieu Nantes, France
  • CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes, France
  • APHP - Groupe Hospitalier Pitié-Salpetrière Paris, France
View Trial Details
Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

NCT00912964

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Homewood, Alabama, United States
  • Huntsville, Alabama, United States
  • Mobile, Alabama, United States
  • Chandler, Arizona, United States
View all 151 locations
View Trial Details

Related conditions